Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of FRK mRNA | affects expression | 21346803
|
C016601 |
4-hydroxytamoxifen |
4-hydroxytamoxifen results in increased expression of FRK mRNA | increases expression | 19901195
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of FRK mRNA | affects expression | 16483693
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of FRK mRNA | decreases expression | 15761015
|
D003513 |
Cycloheximide |
Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of FRK mRNA] | decreases expression|decreases reaction | 11007951
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of FRK mRNA | decreases expression | 20106945
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of FRK mRNA | affects cotreatment|decreases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in increased expression of FRK mRNA | increases expression | 19619570
|
D010634 |
Phenobarbital |
NR1I3 protein affects the reaction [Phenobarbital results in increased expression of FRK mRNA] | affects reaction|increases expression | 19482888
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of FRK mRNA | increases expression | 19482888
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of FRK mRNA | increases expression | 17426115
|
D013749 |
Tetrachlorodibenzodioxin |
Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of FRK mRNA] | decreases expression|decreases reaction | 11007951
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of FRK mRNA | affects cotreatment|decreases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of FRK mRNA | decreases expression | 19619570 11007951 19901195
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
9.10 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
9.10 | 15322242 11752688 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.80 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.30 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
4.52 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.52 | 11473722 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
18.74 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
18.74 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
18.74 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.11 | 11748828 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
16.31 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
16.31 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
16.31 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.06 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.87 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
1.92 | 17289903 14630087 12948864 19861407 16675129 17261762 18497071 17018787 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.92 | 20435547 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.51 | 11589617 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.70 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.93 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
6.78 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
6.78 | 15073043 15553829 16217749 11135700 14691202 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
6.78 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
6.78 | 17173139 1701930 6705139 20007298 20935162 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
5.14 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.28 | 12490120 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.45 | 18670907 16120746 18850075 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.96 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
6.96 | 18566989 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.47 | 4080065 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.31 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
8.18 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.18 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.16 | 8697196 12621046 16354765 15340226 15668235 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
1.86 | 20501625 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.21 | 14669216 17141729 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.38 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
2.51 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.51 | 10048152 20055451 15322242 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
4.23 | 18551238 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.28 | 15213294 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.49 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.70 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.56 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
3.84 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.84 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.89 | 11462148 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
4.19 | 1851702 |
MESH:D004487 |
Edema |
|
pirinixic acid |
7.11 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.11 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.17 | 15322242 16714409 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
4-hydroxytamoxifen |
8.14 | 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
8.14 | 11473722 18566989 19148513 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.18 | 10568697 9294722 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
4.32 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
4.14 | 3922381 11558140 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.97 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.69 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
4.47 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
4.26 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
2.34 | 12903497 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.14 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
14.09 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
14.09 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
14.09 | 19236843 20131406 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.67 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
9.21 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.21 | 20067830 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.46 | 16904648 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.46 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.86 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.41 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.63 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.66 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.51 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
15.69 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
15.69 | 19176532 16221962 19772884 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
15.69 | 12621046 15340226 16120746 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.30 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
4.02 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.31 | 8697196 18606429 15340226 16959395 16354765 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.34 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.14 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.14 | 18670907 18850075 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.93 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
7.55 | 16627594 16393666 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.55 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.51 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.71 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.24 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
6.24 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
13.22 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
13.22 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
13.22 | 15610895 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
2.91 | 15070760 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.97 | 17077332 12560223 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.54 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.55 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
3.93 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
2.16 | 16467208 20471514 17050201 16968895 19850784 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
3.32 | 15213294 17649720 17107899 15336539 19075265 17869043 11468182 16966277 16823087 17217047 9834237 11161223 19035177 12018890 16112521 16330433 19642359 15622746 17712046 16891316 15748426 19225113 16331271 12679006 12712474 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.55 | 16882451 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
2.98 | 21047994 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.47 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.47 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.47 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
2.20 | 19363144 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
11.17 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
11.17 | 19812893 8742319 15975961 21047994 19482888 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
11.17 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
11.17 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
10.42 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
10.42 | 1399818 18308698 17172636 2563599 6150874 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
10.42 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.48 | 15213294 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
2.34 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.34 | 11884234 19555203 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
2.66 | 11408345 17203775 11807958 16891317 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.75 | 19453300 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.05 | 16801185 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
3.22 | 14977855 19549372 15949261 19417148 11468182 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.72 | 16239165 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.94 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
3.23 | 16882451 16105982 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.20 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.16 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
8.69 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
8.69 | 16411023 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.71 | 17484760 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
4.09 | 18551238 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
4.16 | 16624393 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.02 | 17405874 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.97 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.71 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.44 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
10.14 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
10.14 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
3.22 | 10525206 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.85 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
3.59 | 12819281 16049721 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.60 | 17016548 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
4.98 | 12452020 19769630 16624393 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
4.98 | 19401270 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
5.48 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
5.48 | 16965848 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.35 | 19927285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.51 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.76 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
9.48 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
9.48 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.43 | 11118676 11896295 11399792 11222880 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
4.06 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
3.18 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.18 | 16740699 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.76 | 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.28 | 16882103 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.46 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.04 | 18990726 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
4.16 | 16646077 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
6.30 | 18551238 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
6.30 | 4039156 11442880 16876388 3137016 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
5.06 | 6407741 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.11 | 16192470 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
1.86 | 17007042 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.17 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
7.66 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
7.66 | 1399818 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.95 | 19048282 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
4.20 | 15213294 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
5.28 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
5.28 | 12973940 20435036 12845720 11780464 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.55 | 10091137 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.25 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.86 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.51 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.71 | 17120751 |